Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study - Can Fite Biopharma (AM
Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study - Can Fite Biopharma (AMEX:CANF)
Can-Fite BioPharma schedules special shareholder meeting as NYSE American issues non-compliance notice